shortagewatch

Home / Digestive tract and metabolism / Famotidine

ATC A02BA03 · H2-Receptor Antagonists · updated 2 Nov 2026

Famotidine shortage

As of 2 Nov 2026, Famotidine has a reported shortage in 4 of the 16 countries we track (Canada, Ireland, Czechia, Japan), covering 20 products from 13 companies.

Is there a Famotidine shortage?

Yes. As of 2 Nov 2026, Famotidine is reported short in 4 of the 16 countries we track: Canada, Ireland, Czechia, Japan. The earliest expected return is 30 Nov 2026 (Canada). 17 of 20 affected products have no return date. New since 3 Oct 2026: Japan.

Countries4/16
Products20packs or presentations
Companies132 listed
Short since10 Mar 20179.6 years ago
Earliest return30 Nov 2026company estimate
Main reasonIncreased demand
United StatesNo reported shortageCanada4 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIreland1 product shortAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechia1 product shortNorwayNo reported shortageSwedenNo reported shortageJapan14 products shortNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

CanadaIrelandCzechiaJapan
20222023202420252026APO-FAMOTIDINE (10/12/6 BLS)APO-FAMOTIDINE (10/12/6 BLS)FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE) (10FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE) (10 x 2 mL vial / fiole)FAMOTIDINE (100)FAMOTIDINE (100)FAMOTIDINE OMEGA -(WITH PRESERVATIVE,BENZYL FAMOTIDINE OMEGA -(WITH PRESERVATIVE,BENZYL ALCOHOL) (1 x 20mL vial / fiole)Famotidine Clonmel 40 mg film-coated tabletsFamotidine Clonmel 40 mg film-coated tabletsファモチジン注射用10mg「テバ」ファモチジン注射用10mg「テバ」ファモチジン注射用20mg「テバ」ファモチジン注射用20mg「テバ」ファモチジン静注20mg「日新」ファモチジン静注20mg「日新」ファモチジン錠10mg「TCK」ファモチジン錠10mg「TCK」ファモチジン静注液10mg「サワイ」ファモチジン静注液10mg「サワイ」ファモチジン静注液20mg「サワイ」ファモチジン静注液20mg「サワイ」ファモチジン静注液10mg「日医工」ファモチジン静注液10mg「日医工」ファモチジン静注液20mg「日医工」ファモチジン静注液20mg「日医工」ガスター注射液10mgガスター注射液10mgガスター注射液20mgガスター注射液20mgファモチジン静注10mg「杏林」ファモチジン静注10mg「杏林」ファモチジン静注20mg「杏林」ファモチジン静注20mg「杏林」ファモチジン注射液10mg「トーワ」ファモチジン注射液10mg「トーワ」ファモチジン注射液20mg「トーワ」ファモチジン注射液20mg「トーワ」today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Omega2T S2Sawai2 4887Nichi-Iko2Ltl2キョーリンリメディオ2Towa (Pensa)2 4553Apotex1Sanis1Stada1Pro.Med.Cs Praha1Nissin Pharmaceutical1

Listed: Sawai 4887 · Tokyo, Towa (Pensa) 4553 · Tokyo

Compared with similar medicines

ATC group A02BA · H2-Receptor Antagonists
Famotidine4/16Cimetidine2/16Famotidine, Combinations1/16Lafutidine1/16Nizatidine1/16Ranitidine1/16Roxatidine1/16

Affected products

CountryProductCompanySinceExpected backReason
CAAPO-FAMOTIDINE (10/12/6 BLS)APOTEX INC10 Mar 2017not givenManufacturing problem
Disruption of the manufacture of the drug
CAFAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE) (10 x 2 mL vial / fiole)OMEGA LABORATORIES LIMITED2 Mar 202630 Nov 2026Manufacturing problem
Disruption of the manufacture of the drug
CAFAMOTIDINE (100)SANIS HEALTH INC25 May 2026not givenManufacturing problem
Disruption of the manufacture of the drug
CAFAMOTIDINE OMEGA -(WITH PRESERVATIVE,BENZYL ALCOHOL) (1 x 20mL vial / fiole)OMEGA LABORATORIES LIMITED6 Jul 202630 Nov 2026Increased demand
Demand increase for the drug
IEFamotidine Clonmel 40 mg film-coated tabletsClonmel Healthcare Ltd8 Sep 2026not givenIncreased demand
Unexpected increased demand
CZFAMOSAN 20MG 20MG TBL FLM 50 anticipatedPRO.MED.CS Praha a.s.6 Nov 20267 Dec 2026Manufacturing problem
Výrobní důvody
ファモチジン注射用10mg「テバ」T’sファーマ8 Sep 2025not givenQuality problem or recall
Quality problem
ファモチジン注射用20mg「テバ」T’sファーマ1 Dec 2025not givenQuality problem or recall
Quality problem
ファモチジン静注20mg「日新」 limitedNissin Pharmaceutical9 Oct 2026not givenManufacturing problem
ファモチジン錠10mg「TCK」Tatsumi Kagaku15 Oct 2026not givenOther
ファモチジン静注液10mg「サワイ」 limitedSawai20 Oct 2026not givenManufacturing problem
ファモチジン静注液20mg「サワイ」 limitedSawai20 Oct 2026not givenManufacturing problem
ファモチジン静注液10mg「日医工」 limitedNichi-Iko21 Oct 2026not givenIncreased demand
ファモチジン静注液20mg「日医工」 limitedNichi-Iko21 Oct 2026not givenIncreased demand
ガスター注射液10mg limitedLTLファーマ23 Oct 2026not givenIncreased demand
ガスター注射液20mg limitedLTLファーマ23 Oct 2026not givenIncreased demand
ファモチジン静注10mg「杏林」 limitedキョーリンリメディオ26 Oct 2026not givenIncreased demand
ファモチジン静注20mg「杏林」 limitedキョーリンリメディオ26 Oct 2026not givenIncreased demand
ファモチジン注射液10mg「トーワ」 limitedTowa (Pensa)29 Oct 2026not givenIncreased demand
ファモチジン注射液20mg「トーワ」 limitedTowa (Pensa)29 Oct 2026not givenIncreased demand

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Famotidine shortage?

Yes. As of 2 Nov 2026, Famotidine is reported short in 4 of the 16 countries we track: Canada, Ireland, Czechia, Japan. The earliest expected return is 30 Nov 2026 (Canada). 17 of 20 affected products have no return date. New since 3 Oct 2026: Japan.

When will Famotidine be back in stock?

Companies expect supply back from 30 Nov 2026 in Canada; Canada: 30 Nov 2026; Ireland: no date given; Czechia: 7 Dec 2026; Japan: no date given. These are company estimates reported to each authority.

Why is Famotidine in short supply?

The most common reason reported is: increased demand. Reasons by product are listed in the table below.

Which companies have Famotidine shortages?

Omega, T S, Sawai, Nichi-Iko, Ltl, キョーリンリメディオ, Towa (Pensa), Apotex, Sanis, Stada.